Serum Institute Seeks Indemnity, Says "Same Rules For All": Sources

After Pfizer and Moderna, Covishield-maker Serum Institute of India (SII) has asked for indemnity from liability, according to sources. All vaccine makers, whether Indian or foreign, should be granted...

from NDTV News - Special https://ift.tt/3pjasEe